NMQF leadership is closely monitoring the COVID-19 situation. We consider the health, well-being, and safety of our meeting attendees, staff, and the public our top priority. At present, the immediate health risk from COVID-19 in the United States is considered low, both for the general American public and for healthcare professionals who have not had prolonged close contact with patients who have COVID-19.
Read MoreOn November 26, 2018, the Centers for Medicare and Medicaid Services published their proposed rule, Contract Year (CY) 2020 Medicare Advantage and Part D Drug Pricing Proposed Rule (CMS-4180-P) which, according to CMS, contains potential policies that will modernize Part D and Medicare Advantage to lower drug prices and reduce out-of-pocket expenses. … In response to the proposed rule, on November 29, 2019 the National Minority Quality Forum released the following statement:
Read MoreThe National Minority Quality Forum has released the following statement regarding the proposed rule by Department of Health and Human Services that would create incentives to lower list prices and reduce out-of-pocket spending on prescription drugs: …
Read More
